S8809-S9800-S9911TM- Biological Markers in Patients With Follicular Lymphoma Treated on Clinical Trial SWOG-8809, SWOG-9800, or SWOG-9911

计划入组 180 人 · 首次发布于 2009 年 5 月 12 日

A Multiple Dose Study of TD-1211 in Healthy Volunteers and Patients With Opioid-Induced Constipation

计划入组 102 人 · 首次发布于 2009 年 12 月 29 日

SWOG-9342 Chemotherapy in Treating Women Enrolled in the SWOG-8897 Clinical Trial

计划入组 180 人 · 首次发布于 2003 年 1 月 27 日

SWA-1211

ZL-1211

SA-1211

SWOG

United States

山东琳泽阿胶集团（馆陶）制药有限公司

Regenacy Pharmaceuticals LLC

United States

Reduced Dexamethasone Dosing Shows Comparable Survival Outcomes in Multiple Myeloma Treatment

SWOG S1815: Nab-Paclitaxel Addition to Standard Chemotherapy Under Investigation for Advanced Biliary Tract Cancer

SWOG Studies Highlight Biostatistical Expertise in Bladder Cancer and Hodgkin Lymphoma